This announcement is a separate document:
自愿披露关于GR1802注射液启动慢性鼻窦炎伴鼻息肉适应症III期临床试验的公告
Voluntary disclosure regarding the launch of Phase III clinical trial for GR1802 injection for the treatment of chronic sinusitis with nasal polyps.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.